Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs high-dose midazolam for refractory convulsive status epilepticus in children
2013-004396-12Phase 3Terminated
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ketamine in status epilepticus (SE) (2 arms), sponsored by Meyer Children's Hospital IRCCS. Primary endpoint: Resolution of refractory convulsive status epilepticus. Started Jan 2014; status: terminated.
02
Drugs
ketamine
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on 2013-004396-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004396-12.